The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Next the approach <strong>of</strong> Health Canada to managing risk <strong>of</strong> the potent renal carcinogen<br />
ochratoxin A (OTA) in a market-based economy will be discussed. Ochratoxin<br />
occurs naturally in many foods, such as cereal-derived staples as well as other food<br />
commodities such as grapes, raisins, wine and c<strong>of</strong>fee. Health Canada re-evaluated<br />
the tolerable daily intake (TDI), re-evaluated the European TDI and conducted a<br />
probabilistic risk assessment.<br />
1535 GENERATION OF ELECTRICAL POWER WITH<br />
WOODY BIOMASS: A SITE-SPECIFIC TECHNICAL<br />
EVALUATION OF EMISSIONS AND POTENTIAL<br />
HEALTH RISKS.<br />
C. Teaf1, 5 , T. Davis2 , J. Doolittle2 , G. Morris3 , J. Levine4 and D. Covert5 .<br />
1Florida State University, Tallahassee, FL, 2ECT, Inc., Gainesville, FL, 3Green Power<br />
Institute, Berkeley, CA, 4American Renewables, LLC, Boston, MA and 5Hazardous Substance & Waste Management Research, Tallahassee, FL.<br />
<strong>The</strong> generation <strong>of</strong> electric power on a commercial scale using woody biomass is receiving<br />
attention and achieving broader application in some areas <strong>of</strong> the US. As<br />
with any combustion facility, technical evaluations regarding potential human<br />
health risks or ecological impacts from a biomass-fired power plant must include an<br />
analysis <strong>of</strong> the specific characteristics <strong>of</strong> the proposed facility, including plant size,<br />
fuel quantities and types, boiler engineering, emissions control equipment, and applicable<br />
state or federal regulatory limits. A detailed preconstruction emission and<br />
risk evaluation <strong>of</strong> these and other factors was conducted concerning a woody biomass-fired<br />
facility that was undergoing regulatory review in Northcentral Florida.<br />
Projected emissions were modeled according to standard USEPA approaches (e.g.,<br />
AERMOD) and impacts at all locations were shown to be well below all applicable<br />
air quality standards and guidelines. An evaluation <strong>of</strong> potential deposition rates and<br />
environmental impacts for specific Hazardous Air Pollutants (HAPs; e.g.,<br />
dioxins/furans, mercury) was conducted according to USEPA protocols.<br />
Environmental concentrations <strong>of</strong> modeled HAPs showed that potential risks at all<br />
locations were well below acceptable limits, based upon comparisons with relevant<br />
standards and guidelines for air, soil, water, sediments and edible fish tissue.<br />
1536 EMERGENCY DO NOT CONSUME/DO NOT USE<br />
PUBLIC NOTIFICATIONS FOR DIRECT DRINKING<br />
WATER ADDITIVES.<br />
C. J. McLellan, C. C. Willhite, V. S. Bhat and G. L. Ball. NSF International,<br />
Ann Arbor, MI.<br />
Regulatory authorities and water purveyors are becoming increasingly concerned<br />
with accidental or intentional adulteration <strong>of</strong> municipal drinking water supplies. As<br />
a consequence, there is a need for short-term (acute) acceptable oral, topical, and<br />
ocular exposure levels to be used in emergency situations to notify the public. <strong>The</strong>se<br />
levels, designated as Specific Concentration Levels (SCLs), have been derived for a<br />
number <strong>of</strong> direct drinking water additives using an approach analogous to the U.S<br />
EPA Reference Dose (RfD) and Health Advisory approaches. <strong>The</strong> SCLs were used<br />
to calculate emergency “Do Not Consume” levels based on the default 10 kg body<br />
weight and 1 L/day water consumption <strong>of</strong> a child, which is consistent with methods<br />
used to calculate one-day Health Advisories. As examples, a Do Not Consume<br />
level <strong>of</strong> 600 mg/L was derived for blended phosphates based on acute diarrhea after<br />
ingestion <strong>of</strong> a single oral dose <strong>of</strong> mono- and dibasic monophosphates. Based on<br />
mild irritation after topical application <strong>of</strong> 0.2% sodium metaphosphate to intact<br />
skin <strong>of</strong> sensitive volunteers, a Do Not Use limit <strong>of</strong> 8000 mg PO4 /L was assigned.<br />
Given the eye irritation seen in rabbits after direct instillation <strong>of</strong> 0.2% sodium<br />
metaphosphate, an acute ocular contact limit <strong>of</strong> 60 mg PO4 /L served as the overall<br />
Do Not Use level. <strong>The</strong>se Do Not Consume and ocular or skin Do Not Use concentrations<br />
for phosphates also apply to acute exposures to zinc orthophosphate. A<br />
Do Not Consume concentration <strong>of</strong> 7 mg/L was derived for zinc from zinc orthophosphate<br />
based on clinical reports <strong>of</strong> gastrointestinal distress. While there were<br />
no empirical data upon which to derive a Do Not Use advisory for ocular or skin<br />
contact to zinc from zinc orthophosphate, potential irritation associated with the<br />
orthophosphate moiety is considered to be the governing factor for the ocular or<br />
topical use limits. To utilize the values derived here, the risk manager must take into<br />
account the exposure scenario and the pH <strong>of</strong> the water as well as the public health<br />
and safety consequences associated with a lack <strong>of</strong> water.<br />
1537 ENDPOINT SENSITIVITY IN FISH ENDOCRINE<br />
DISRUPTION ASSAYS: REGULATORY IMPLICATIONS.<br />
Z. Dang. RIVM, Bilthoven, Netherlands. Sponsor: J. Bessems.<br />
Identifying potential endocrine disrupting chemicals (EDCs) needs screening for<br />
elucidating mode <strong>of</strong> action (MOA) evidenced by biomarker endpoints and testing<br />
for intrinsic toxicological properties showed by apical endpoints. Risk assessment,<br />
330 SOT 2011 ANNUAL MEETING<br />
however, is mainly based on apical endpoints but not MOA endpoints. Fish 21-day<br />
assay (e.g. OECD TG229) is considered as a screen. But this assay includes both<br />
biomarker and apical endpoints. This study explores the utility <strong>of</strong> results <strong>of</strong> 21-day<br />
fish assay for risk assessment. Endpoint sensitivity was analysised by compiling data<br />
from 142 individual studies for 21-day fish assay, 38 studies for fish sexual development<br />
test (FSDT) and 6 studies for fish full-life cycle test (FFLC), encompassing 62<br />
chemicals with different MOAs. Conclusions from this analysis include: 1) vitellogenin<br />
(VTG), fecundity and gonad histology are the most sensitive endpoints for<br />
fathead minnow, medaka and zebrafish in 21-day fish assays; secondary sex characteristics<br />
(SSC) is a less sensitive endpoint and is likely inadequate to detect all<br />
known MOAs. 2) Results <strong>of</strong> biomarker endpoints like VTG and apical endpoints<br />
like fecundity from 21-day fish assay could be equally used for risk assessment. 3)<br />
Most <strong>of</strong> low observed effect concentrations (LOEC) were comparable for 21-day<br />
fish assay, FSDT and FFLC, which further support that data from 21-day fish assay<br />
can be used for risk assessement. However, significant difference in LOECs was also<br />
noted in some chemicals, suggesting that comprehensive endpoint sensitivity analysis<br />
is needed. This paper emphasizes that a weight <strong>of</strong> evidence approach is important<br />
to the decision making and testing strategy <strong>of</strong> EDCs.<br />
1538 MODELING THE IMPACT OF SHORT TERM LEAD<br />
EXPOSURE ON BLOOD LEAD LEVELS IN YOUNG<br />
CHILDREN.<br />
J. Donohue 1 , W. Mendez 2 and A. Shapiro 2 . 1 Office <strong>of</strong> Water, U.S. EPA,<br />
Washington, DC and 2 ICF International, Fairfax, VA. Sponsor: E. Doyle.<br />
<strong>The</strong> Environmental Protection Agency (EPA) Integrated Exposure Uptake<br />
Biokinetic (IEUBK) Model can predict the risk <strong>of</strong> elevated blood lead levels in children<br />
exposed to environmental lead from a variety <strong>of</strong> sources. A major limitation <strong>of</strong><br />
the model is its inability to predict the impact <strong>of</strong> short term or episodic increases in<br />
lead exposure on blood lead levels. <strong>The</strong> Office <strong>of</strong> Water (OW) contracted with ICF<br />
International to determine if the IEUBK model could be adapted so that it could<br />
predict changes in blood lead levels over timeframes consistent with a drinking<br />
water utility’s quarterly monitoring program. ICF updated the background levels <strong>of</strong><br />
lead in ambient air, soils, household dust, drinking water and diet used by the<br />
model. <strong>The</strong>y devised an interface for the model that facilitated data entry and batch<br />
operation. <strong>The</strong> model was calibrated to ensure that the background blood lead projections<br />
(with typical drinking water exposure concentrations) were consistent with<br />
the distributions <strong>of</strong> blood lead levels seen in the Centers for Disease Control and<br />
Prevention’s National Health and Nutrition Examination Survey (NHANES) monitoring<br />
program. <strong>The</strong> calibrated model has been used to estimate impacts on blood<br />
lead distributions in children exposed to increases in lead from drinking water. <strong>The</strong><br />
model was found to provide consistent results for exposure averaging timeframes as<br />
short as three months. Monitoring under the EPA Lead and Copper Rule involves<br />
measuring lead concentrations in first-draw tap samples after the water has been<br />
stagnant for at least six hours which does not represent average human consumption.<br />
However, the adapted IEUBK model allows the OW to examine the incremental<br />
impact <strong>of</strong> hypothetical increases in average daily lead exposures on blood<br />
lead levels in young children and thereby inform projections <strong>of</strong> potential health<br />
risks. [<strong>The</strong> views expressed in this abstract are those <strong>of</strong> the authors and do not necessarily<br />
reflect the views or policies <strong>of</strong> the U.S. EPA.]<br />
1539 THE COUNCIL OF CANADIAN ACADEMIES EXPERT<br />
PANEL ON THE INTEGRATED TOXICITY TESTING OF<br />
PESTICIDES.<br />
M. Trainer and L. Ritter 1, 2 . 1 Council <strong>of</strong> Canadian Academies, Ottawa, ON, Canada<br />
and 2 School <strong>of</strong> Environmental Sciences, University <strong>of</strong> Guelph, Guelph, ON, Canada.<br />
Canada relies on well-established animal-based models and test systems to assess the<br />
safety and efficacy <strong>of</strong> chemicals and pharmaceuticals, including pesticides.<br />
Alternative testing strategies, including in vitro assays and “omics” technologies,<br />
represent an exciting opportunity for the development <strong>of</strong> tests that can evaluate a<br />
larger number <strong>of</strong> compounds, in systems that may more reliably predict potential<br />
adverse effects in humans. This approach also has the potential to identify the cellular<br />
mechanisms that may be the root cause <strong>of</strong> adverse effects. <strong>The</strong>se new approaches<br />
may reduce the reliance on animal-based test systems and increase the efficiency<br />
and volume <strong>of</strong> testing, while maintaining the highest levels <strong>of</strong> scientific<br />
rigour. New legislation in the US and Europe will significantly increase the testing<br />
burden that cannot be met by the current toxicity testing paradigm. Integrated approaches<br />
for toxicity assessment may represent the means by which adequate safety<br />
testing, harmonized internationally, can address this challenge. <strong>The</strong> Pest<br />
Management Regulatory Agency (PMRA) <strong>of</strong> Health Canada requested that the<br />
Council <strong>of</strong> Canadian Academies convene an expert panel to evaluate the use <strong>of</strong> integrated<br />
testing strategies (IATA) for the regulatory risk assessment <strong>of</strong> pesticides.<br />
Pesticide formulations represent, on the one hand, one <strong>of</strong> the most data-rich chem-